Does Ozempic Need to Be Refrigerated? Check Your Product First

Check U.S. Ozempic storage rules for pens, prefilled syringes and tablets, plus what to record if medication was left out or overheated.

Majesta Health Editorial TeamReviewed by Majesta team
Published 11 min read

Check the product on your carton first. For the U.S. Ozempic multidose injection pen, refrigeration is required before first use: 36°F to 46°F (2°C to 8°C). After first use, the pen has a 56-day use period and can be kept either within that refrigerator range or at 59°F to 86°F (15°C to 30°C). A single-dose prefilled syringe and Ozempic tablets have different instructions. U.S. injection label, §16, U.S. tablet label, §16

The important question is which instructions match the product in your hands. This guide explains the U.S. label directions and provides a storage-history worksheet for a conversation with your pharmacist. If a product was frozen, overheated, or kept under uncertain conditions, an article cannot determine whether it remains suitable for use.

Start with the carton: pen, prefilled syringe, or tablets?

Read the product name, container, and pharmacy label. The U.S. prescribing information describes three presentations with different storage rules:

  • A multidose injection pen: one pen contains multiple doses for one person. Its storage directions distinguish the period before first use from the period afterward.
  • A single-dose prefilled injection syringe: each syringe is used once. Its time outside refrigeration differs from the multidose pen's in-use period.
  • Tablets: these have their own room-temperature, bottle, and moisture-protection instructions.

Use your actual packaging to identify the presentation. If it is unclear, ask the dispensing pharmacy to identify it before following the instructions below. The directions here do not establish that a particular presentation is stocked locally, interchangeable with another, or appropriate for your treatment. Injection label, §16, tablet label, §16

Ozempic storage temperatures and time limits

Multidose pen, before first use

Labeled storage: Refrigerate at 36°F to 46°F (2°C to 8°C).

Storage window and handling: Keep it in its carton until administration. The label permits storage under these conditions until the package expiration date. Keep it away from the refrigerator's cooling element; do not freeze it.

Multidose pen, after first use

Labeled storage: Either 59°F to 86°F (15°C to 30°C) or refrigerated at 36°F to 46°F (2°C to 8°C).

Storage window and handling: Discard 56 days after first use, even if medicine remains. Do not use it after the package expiration date. Keep the cap on, store it without an injection needle attached, and protect it from excessive heat and sunlight. Refrigeration does not restart this period.

Single-dose prefilled syringe

Labeled storage: Refrigerate at 36°F to 46°F (2°C to 8°C), up to its package expiration date under those conditions.

Storage window and handling: If needed, the label allows 46°F to 86°F (8°C to 30°C) for up to 28 days. Record when it leaves refrigeration; discard it if unused within 28 days. Do not use an expired syringe or one that froze, even after thawing. Keep it in its carton for light protection. Discard it after its single use.

Tablets

Labeled storage: Store at 68°F to 77°F (20°C to 25°C).

Storage window and handling: The label permits excursions to 59°F to 86°F (15°C to 30°C). Keep tablets in their original closed bottle until use; do not move them to another container. Keep the bottle dry and away from moisture. The injection time limits do not apply.

Sources: Novo Nordisk U.S. injection prescribing information, §16, and the pen and syringe Instructions for Use; U.S. tablet prescribing information, §16, and Medication Guide. Revision dates and page references appear below. Follow the current directions supplied with your own product. A permitted temperature excursion is different from a recommendation to keep tablets at either temperature extreme indefinitely.

Do not use an Ozempic injection that has been frozen. Thawing it does not remove that label instruction. A refrigerator temperature below the recommended range is a reason to check the storage history; it does not, by itself, establish that the medication actually froze. Injection label, §16

What starts the pen's 56-day period?

The U.S. pen directions specify after first use. Opening the outer carton is a different event. Record the date the pen was first used and the package expiration date. The Instructions for Use say to discard the pen after 56 days even if medicine remains; do not keep it past its expiration date. Pen Instructions for Use, PDF pages 13, 15 and 17

Putting an in-use pen back in the refrigerator does not give it another 56 days. Earlier storage outside refrigeration can also matter. In its supplemental pen-related medical storage guidance for U.S. healthcare professionals, Novo Nordisk gives a use-or-discard limit of 56 days after exposure above 46°F. That guidance is framed for a product that has not been exposed below 36°F or above 86°F and appears alongside the pen's before/after-first-use table. It does not replace the separate syringe or tablet instructions. Novo Nordisk storage and stability guidance

If a pen was warm before first use, dates overlap, or the temperature history is uncertain, ask the dispensing pharmacist or manufacturer to confirm the applicable discard date. Keep the earlier exposure date, first-use date, and printed expiration date available. Do not assume that starting the pen or refrigerating it again creates a fresh period.

This guide and worksheet provide no countdown or calculated discard date. Record known event dates and any discard date specifically confirmed by your dispensing pharmacist or the manufacturer. A calculation based on an assumed first-use date can miss an earlier excursion, an expiration date, or the instructions for a different container.

The prefilled syringe has a separate 28-day instruction

For the single-dose prefilled syringe, the U.S. Instructions for Use allow storage out of the refrigerator at 46°F to 86°F (8°C to 30°C) for up to 28 days. They say to record the date it is removed from the refrigerator and to discard it if it has not been used within 28 days. Keep that date with the carton. The 56-day multidose-pen period does not apply to this syringe. Do not assume that putting a syringe back in the refrigerator resets its deadline; ask the dispensing pharmacist or manufacturer how to handle a history of repeated temperature changes. Injection label, prefilled-syringe Instructions for Use, PDF page 19

Ozempic was left out of the fridge: what information matters?

Begin with the presentation. Then record the facts that will help the dispensing pharmacist or manufacturer answer the question:

  1. Which product and container is it? Read the carton and pharmacy label, including the country labeling.
  2. What happened, and when? Note when it left recommended storage, any return to refrigeration, and any earlier excursions. For a multidose pen, include whether and when it was first used.
  3. What temperatures are known? Record a thermometer reading or the best available temperature evidence, with the duration. Mark missing information as unknown.
  4. Were freezing, excessive heat, sunlight, or moisture involved? Note the original container and any visible change as well.

A night on a counter, a hot car, a freezer compartment, and an uncertain hotel refrigerator are different histories. Being indoors or inside a cooler does not establish that the relevant temperature range was maintained. Follow the visual inspection directions in your product's Instructions for Use. A normal appearance still cannot confirm that earlier storage conditions were acceptable.

When the history falls outside the applicable label directions or is unclear, contact the dispensing pharmacist or manufacturer before using the affected product. They can assess the particular presentation and history. If the uncertainty affects an upcoming prescribed dose, ask your pharmacist or prescriber for a treatment plan promptly. Do not take an extra dose, switch products, or change your dosing schedule based on this storage guide.

Printable storage-history worksheet

Open the printable storage-history worksheet, or copy the fields below, and keep the note with your packaging for the pharmacy conversation. Mark anything you cannot establish as unknown. If the syringe removal date is unknown, do not invent a start date or a new deadline.

  • Exact product, presentation, and country labeling: ____________
  • Package expiration date: ____________
  • Multidose pen: first-use date, or still unused: ____________
  • Single-dose prefilled syringe: date removed from refrigeration: ____________
  • When removed from recommended storage; any earlier excursions: ____________
  • When returned, if applicable; any other moves: ____________
  • Lowest/highest known temperature, duration, and how measured: ____________
  • Possible freezing, excessive heat, sunlight, or moisture: ____________
  • Original carton/bottle available; container condition or visible changes: ____________
  • Date of pharmacist/manufacturer conversation and guidance received: ____________
  • Discard date, if specifically confirmed by the pharmacist/manufacturer: ____________

Keep the completed worksheet private. No name, diagnosis, address, or contact details are needed here, and there is no reason to submit the completed note to Majesta or a public AI tool. The worksheet organizes facts; it does not issue a usable/not-usable verdict or a dosing recommendation.

Traveling with Ozempic

Decide how you will maintain the product's storage conditions before departure. Keep the relevant packaging directions available and avoid assuming that a bag, cooling pack, vehicle, or hotel refrigerator provides the right temperature.

Our guide to traveling with semaglutide and tirzepatide covers broader travel planning. For Ozempic storage, use the directions for your exact presentation and ask your pharmacist about a plan that fits your itinerary.

Frequently asked questions

Does Ozempic need to be refrigerated before first use?

The U.S. multidose injection pen should be refrigerated at 36°F to 46°F (2°C to 8°C) before first use. The single-dose prefilled syringe also has refrigerated storage directions, with its own allowance outside refrigeration. Tablets follow separate room-temperature directions. Check your carton first. Injection label, §16, tablet label, §16

How long can Ozempic be out of the fridge?

For the U.S. multidose pen after first use, the label permits 56 days at 59°F to 86°F (15°C to 30°C), or refrigeration within the same 56-day period. Injection label, §16

For a pen left out before first use, Novo Nordisk's supplemental pen-related guidance gives a use-or-discard limit of 56 days after exposure above 46°F, within its stated bounds of no exposure below 36°F or above 86°F. That guidance is intended for U.S. healthcare professionals. Ask your dispensing pharmacist or the manufacturer to confirm the applicable discard date. Supplemental manufacturer storage guidance

The single-dose prefilled syringe has a different allowance: up to 28 days at 46°F to 86°F (8°C to 30°C), if needed. Its Instructions for Use say to record the date it leaves the refrigerator and discard it if unused within 28 days. These periods do not automatically clear an uncertain or out-of-range storage history. Injection label, §16 and syringe Instructions for Use

Can I refrigerate an Ozempic pen again after using it?

The U.S. label permits an in-use multidose pen to be kept in the stated refrigerator range during its 56-day period. That period continues; it does not restart when the pen goes back into the refrigerator. An earlier excursion or unknown temperature still needs product-specific advice. Injection label, §16

Can I use Ozempic if it froze and then thawed?

The U.S. injection label says not to use it after freezing. Contact the dispensing pharmacy about the affected product and next steps. Your pharmacist or prescriber can advise about your treatment schedule; this article does not provide a replacement-dose plan. Injection label, §16

What if Ozempic was left in a hot car or out overnight?

The duration alone cannot answer that question. Identify the presentation and record the time, temperatures, prior use, and any earlier excursions. If those facts are unknown or outside the applicable directions, ask the dispensing pharmacist or manufacturer before using it.

Should Ozempic tablets follow the pen's storage rules?

No. The U.S. tablet directions specify 68°F to 77°F (20°C to 25°C), with permitted excursions to 59°F to 86°F (15°C to 30°C). Keep the original bottle closed, dry, and protected from moisture; do not transfer the tablets to another container. The pen's 56-day rule does not apply. Tablet label, §16 and Medication Guide

Sources and scope

This educational guide uses U.S. manufacturer labeling and supplemental storage guidance checked on October 15, 2026. The review covered product identification and the relevant storage, handling, and patient instructions:

These directions do not cover other semaglutide brands, compounded preparations, or non-U.S. packages. Follow the current instructions provided with your product and seek product-specific guidance when its storage history is uncertain.

Sources

This article is based on the following primary sources. Links open the original documents.

  1. 1.Ozempic injection U.S. prescribing information and Instructions for Use · Novo Nordisk · accessed
  2. 2.Ozempic tablets U.S. prescribing information and Medication Guide · Novo Nordisk · accessed
  3. 3.GLP-1 receptor agonists: storage and stability · Novo Nordisk Medical · accessed

Telehealth prescribing rules differ by state. Read the state-by-state guide.

Reviewed by Majesta team

Majesta Health Editorial Team

Clinical Editorial Team

Majesta Health articles are written against primary sources (FDA labeling, NIH and CDC publications, state statutes) and each one passes a documented compliance review before publication. Where an article cites external sources, they are listed at the end of that article so you can check them yourself. No article currently carries an individual physician review; when a physician reviews an article, that page will show the reviewer's name, NPI and review date.

How this article was prepared
  • Written against primary sources: FDA labeling and safety communications, NIH and CDC publications, state statutes and medical board rules
  • Documented compliance review against FDA, FTC and LegitScript requirements before publication
  • External sources, where an article cites them, are listed at the end of that article with links to the original documents
  • Compounded medications are described as not FDA-approved as final products on every page that mentions them
Have a question for our medical team? See our full clinical team page or contact support.